548 related articles for article (PubMed ID: 33486379)
21. Single-cell expression profiles of
Lü M; Qiu L; Jia G; Guo R; Leng Q
Aging (Albany NY); 2020 Oct; 12(20):19880-19897. PubMed ID: 33104520
[TBL] [Abstract][Full Text] [Related]
22. COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella.
Méry G; Epaulard O; Borel AL; Toussaint B; Le Gouellec A
Front Immunol; 2020; 11():1714. PubMed ID: 32793244
[TBL] [Abstract][Full Text] [Related]
23. Targeting TMPRSS2 in SARS-CoV-2 Infection.
Baughn LB; Sharma N; Elhaik E; Sekulic A; Bryce AH; Fonseca R
Mayo Clin Proc; 2020 Sep; 95(9):1989-1999. PubMed ID: 32861340
[TBL] [Abstract][Full Text] [Related]
24. SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors.
Stilhano RS; Costa AJ; Nishino MS; Shams S; Bartolomeo CS; Breithaupt-Faloppa AC; Silva EA; Ramirez AL; Prado CM; Ureshino RP
FASEB J; 2020 Nov; 34(11):14103-14119. PubMed ID: 32965736
[TBL] [Abstract][Full Text] [Related]
25. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
Verdecchia P; Cavallini C; Spanevello A; Angeli F
Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
[TBL] [Abstract][Full Text] [Related]
26. Environmental pollution and COVID-19: the molecular terms and predominant disease outcomes of their sweetheart agreement.
Colacci A; Bortone G; Maffei G; Marchesi S; Mescoli A; Parmagnani F; Pillo G; Ranzi A; Rotondo F; Serra S; Vaccari M; Zauli Sajani S; Mascolo MG; Jacobs MN
Epidemiol Prev; 2020; 44(5-6 Suppl 2):169-182. PubMed ID: 33412808
[TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
Elife; 2020 May; 9():. PubMed ID: 32452762
[TBL] [Abstract][Full Text] [Related]
28. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome.
Devaux CA; Rolain JM; Raoult D
J Microbiol Immunol Infect; 2020 Jun; 53(3):425-435. PubMed ID: 32414646
[TBL] [Abstract][Full Text] [Related]
29. Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.
Dubuc I; Prunier J; Lacasse É; Gravel A; Puhm F; Allaeys I; Archambault AS; Gudimard L; Villano R; Droit A; Flamand N; Boilard É; Flamand L
Front Immunol; 2022; 13():893792. PubMed ID: 35812400
[TBL] [Abstract][Full Text] [Related]
30. Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.
Drak Alsibai K
Med Hypotheses; 2020 Oct; 143():109893. PubMed ID: 32512290
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets.
Bellucci G; Ballerini C; Mechelli R; Bigi R; Rinaldi V; Reniè R; Buscarinu MC; Baranzini SE; Madireddy L; Matarese G; Salvetti M; Ristori G
F1000Res; 2020; 9():992. PubMed ID: 33456761
[No Abstract] [Full Text] [Related]
32. Dysregulation of endocytic machinery and ACE2 in small airways of smokers and COPD patients can augment their susceptibility to SARS-CoV-2 (COVID-19) infections.
Eapen MS; Lu W; Hackett TL; Singhera GK; Thompson IE; McAlinden KD; Hardikar A; Weber HC; Haug G; Wark PAB; Chia C; Sohal SS
Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L158-L163. PubMed ID: 33174446
[TBL] [Abstract][Full Text] [Related]
33. Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?
Jagat J M; Kalyan K G; Subir R
Diabetes Metab Syndr; 2020; 14(5):829-831. PubMed ID: 32540737
[TBL] [Abstract][Full Text] [Related]
34. Identification of biomarkers and pathways for the SARS-CoV-2 infections that make complexities in pulmonary arterial hypertension patients.
Taz TA; Ahmed K; Paul BK; Al-Zahrani FA; Mahmud SMH; Moni MA
Brief Bioinform; 2021 Mar; 22(2):1451-1465. PubMed ID: 33611340
[TBL] [Abstract][Full Text] [Related]
35. Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection?
Moin ASM; Al-Qaissi A; Sathyapalan T; Atkin SL; Butler AE
Front Endocrinol (Lausanne); 2021; 12():665134. PubMed ID: 34248841
[TBL] [Abstract][Full Text] [Related]
36. COVID-19 Pandemic and Male Fertility: Clinical Manifestations and Pathogenic Mechanisms.
Abdel-Moneim A
Biochemistry (Mosc); 2021 Apr; 86(4):389-396. PubMed ID: 33941061
[TBL] [Abstract][Full Text] [Related]
37. An investigation into the molecular basis of cancer comorbidities in coronavirus infection.
Facchiano A; Facchiano F; Facchiano A
FEBS Open Bio; 2020 Nov; 10(11):2363-2374. PubMed ID: 32970391
[TBL] [Abstract][Full Text] [Related]
38. Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis.
Rosso C; Demelas C; Agostini G; Abate ML; Vernero M; Caviglia GP; D'Amato D; Armandi A; Tapparo M; Guariglia M; Troshina G; Massano A; Olivero A; Nicolosi A; Zannetti A; Pellicano R; Ciancio A; Saracco GM; Ribaldone DG; Bugianesi E; Fagoonee S
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366497
[TBL] [Abstract][Full Text] [Related]
39. Impact of Diabetes in Patients Diagnosed With COVID-19.
Abu-Farha M; Al-Mulla F; Thanaraj TA; Kavalakatt S; Ali H; Abdul Ghani M; Abubaker J
Front Immunol; 2020; 11():576818. PubMed ID: 33335527
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide screening of SARS-CoV-2 infection-related genes based on the blood leukocytes sequencing data set of patients with COVID-19.
Gao X; Liu Y; Zou S; Liu P; Zhao J; Yang C; Liang M; Yang J
J Med Virol; 2021 Sep; 93(9):5544-5554. PubMed ID: 34009691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
